// App-Quantinova.ai

SAT0112 : EFFECT OF RITUXIMAB ON IMMUNOGLOBULIN LEVELS AND RISK OF ASSOCIATED INFECTION

Researchers

Presenter

  • S. Khalid

Principal Investigators

  • R. Smith

  • L. Yalakki

Medical Centers

  • Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Salisbury District Hospital, Rhuematology, Salisbury, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved